JP2015521189A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521189A5
JP2015521189A5 JP2015513183A JP2015513183A JP2015521189A5 JP 2015521189 A5 JP2015521189 A5 JP 2015521189A5 JP 2015513183 A JP2015513183 A JP 2015513183A JP 2015513183 A JP2015513183 A JP 2015513183A JP 2015521189 A5 JP2015521189 A5 JP 2015521189A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
optionally
cycloalkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015513183A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015521189A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/060634 external-priority patent/WO2013174931A1/en
Publication of JP2015521189A publication Critical patent/JP2015521189A/ja
Publication of JP2015521189A5 publication Critical patent/JP2015521189A5/ja
Pending legal-status Critical Current

Links

JP2015513183A 2012-05-23 2013-05-23 ウイルス性疾患の治療、改善又は予防に有用な7−オキソ−4,7−ジヒドロ−ピラゾロ[1,5−a]ピリミジン誘導体 Pending JP2015521189A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261650725P 2012-05-23 2012-05-23
US61/650,725 2012-05-23
PCT/EP2013/060634 WO2013174931A1 (en) 2012-05-23 2013-05-23 7-oxo-4,7 -dihydro- pyrazolo [1, 5 -a] pyrimidine derivatives which are useful in the treatment, amelioration or prevention of a viral disease

Publications (2)

Publication Number Publication Date
JP2015521189A JP2015521189A (ja) 2015-07-27
JP2015521189A5 true JP2015521189A5 (cg-RX-API-DMAC7.html) 2016-07-14

Family

ID=48669866

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015513183A Pending JP2015521189A (ja) 2012-05-23 2013-05-23 ウイルス性疾患の治療、改善又は予防に有用な7−オキソ−4,7−ジヒドロ−ピラゾロ[1,5−a]ピリミジン誘導体

Country Status (11)

Country Link
US (2) US20130317021A1 (cg-RX-API-DMAC7.html)
EP (1) EP2861232A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015521189A (cg-RX-API-DMAC7.html)
KR (1) KR20150014506A (cg-RX-API-DMAC7.html)
CN (1) CN104507481B (cg-RX-API-DMAC7.html)
BR (1) BR112014029006A2 (cg-RX-API-DMAC7.html)
CA (1) CA2874253A1 (cg-RX-API-DMAC7.html)
HK (1) HK1204987A1 (cg-RX-API-DMAC7.html)
MX (1) MX2014014109A (cg-RX-API-DMAC7.html)
RU (1) RU2014146778A (cg-RX-API-DMAC7.html)
WO (1) WO2013174931A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517079A (ja) 2011-06-22 2014-07-17 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
WO2013174930A2 (en) * 2012-05-23 2013-11-28 Savira Pharmaceuticals Gmbh 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
EP3418281B1 (en) 2012-12-07 2020-09-30 Vertex Pharmaceuticals Inc. Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases
CN105980386B (zh) 2013-03-13 2021-08-13 基因泰克公司 吡唑并化合物及其用途
EP2970288A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2970286A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Inc. Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
JP2016512239A (ja) 2013-03-15 2016-04-25 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Atrキナーゼの阻害剤として有用な化合物
EP3077397B1 (en) 2013-12-06 2019-09-18 Vertex Pharmaceuticals Inc. 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
ES2777608T3 (es) 2014-06-05 2020-08-05 Vertex Pharma Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útiles como inhibidores de ATR cinasa, la preparación de dicho compuesto y diferentes formas sólidas del mismo
CA2950780C (en) 2014-06-17 2023-05-16 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of chk1 and atr inhibitors
MX2016016666A (es) 2014-07-01 2017-08-08 Rempex Pharmaceuticals Inc Derivados de acido boronico y usos terapeuticos de los mismos.
WO2016005330A1 (en) 2014-07-07 2016-01-14 F. Hoffmann-La Roche Ag Dihydropyridopyrazine-1,8-diones and their use in the treatment, amelioration or prevention of viral diseases
MX385402B (es) 2015-04-28 2025-03-18 Shionogi & Co Derivados de piridona policiclica sustituida y profarmaco de los mismos.
US20170081331A1 (en) 2015-09-18 2017-03-23 F. Hoffmann-La Roche Ag Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease
WO2017059357A1 (en) 2015-09-30 2017-04-06 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna damaging agents and atr inhibitors
MA44080A (fr) 2015-12-15 2018-10-24 Shionogi & Co Médicament pour traiter la grippe caractérisé en ce qu'il comprend une combinaison d'un inhibiteur d'endonucléase coiffe-dépendante avec un médicament antigrippal
WO2018001948A1 (en) 2016-06-29 2018-01-04 F. Hoffmann-La Roche Ag Pyridazinone-based broad spectrum anti-influenza inhibitors
CR20190123A (es) 2016-08-10 2019-04-30 Shionogi & Co Composiciones farmacéuticas que contienen derivados de piridona policíclicos sustituídos y profármacos de los mismos
WO2018071283A1 (en) * 2016-10-12 2018-04-19 Merck Sharp & Dohme Corp. Kdm5 inhibitors
EP3525786A4 (en) * 2016-10-12 2020-03-18 Merck Sharp & Dohme Corp. KDM5 INHIBITORS
US10738056B2 (en) 2017-09-15 2020-08-11 Aduro Biotech Inc. Pyrazolopyrimidinone compounds and uses thereof
CN111670189A (zh) * 2018-01-31 2020-09-15 爱尔兰詹森科学公司 对rsv具有活性的环烷基取代的吡唑并嘧啶
CN113620977B (zh) * 2021-08-24 2024-02-02 江苏弘和药物研发有限公司 一种噻唑烷并嘧啶酮乙酸的合成方法
CN117304133A (zh) * 2023-09-26 2023-12-29 华南农业大学 一种具有噻唑侧链的截短侧耳素衍生物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5475109A (en) 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US6559145B2 (en) * 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
DE60319820T2 (de) * 2002-06-04 2009-03-26 Schering Corp. Pyrazoloä1,5-aüpyrimidin-verbindungen als antivirale agentien
US7550463B2 (en) 2004-09-15 2009-06-23 Shionogi & Co., Ltd. Carbamoylpyridone derivatives having inhibitory activity against HIV integrase
EP1888581A2 (en) 2005-05-16 2008-02-20 Gilead Sciences, Inc. Hiv-integrase inhibitor compounds
US20110112086A1 (en) * 2006-06-08 2011-05-12 Cylene Pharmaceuticals, Inc. Pyridinone analogs
JP5697163B2 (ja) 2009-03-26 2015-04-08 塩野義製薬株式会社 置換された3−ヒドロキシ−4−ピリドン誘導体
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
WO2011000566A2 (en) 2009-06-30 2011-01-06 Savira Pharmaceuticals Gmbh Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
WO2013174930A2 (en) * 2012-05-23 2013-11-28 Savira Pharmaceuticals Gmbh 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease

Similar Documents

Publication Publication Date Title
JP2015521189A5 (cg-RX-API-DMAC7.html)
JP2016518305A5 (cg-RX-API-DMAC7.html)
JP2015517555A5 (cg-RX-API-DMAC7.html)
JP2015524457A5 (cg-RX-API-DMAC7.html)
JP2016508145A5 (cg-RX-API-DMAC7.html)
JP2014530837A5 (cg-RX-API-DMAC7.html)
RU2014146778A (ru) Производные 7-оксо-4,7-дигидропиразоло[1,5-а]пиримидина, которые пригодны для лечения, уменьшения интенсивности или предупреждения вирусного заболевания
JP2016503797A5 (cg-RX-API-DMAC7.html)
RU2014120421A (ru) Производные гетероарилгидроксамовой кислоты и их применение при лечении, облегчении течения или профилактике вирусных заболеваний
JP2013512277A5 (cg-RX-API-DMAC7.html)
JP2010523670A5 (cg-RX-API-DMAC7.html)
JP2013537203A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2016505637A5 (cg-RX-API-DMAC7.html)
JP2011528713A5 (cg-RX-API-DMAC7.html)
AR076837A1 (es) Agentes antiinflamatorios como compuestos virostaticos.
JP2014500295A5 (cg-RX-API-DMAC7.html)
JP2014521625A5 (cg-RX-API-DMAC7.html)
RU2015126015A (ru) Новые улавливатели в лечении макулодистрофии
CA2874250A1 (en) 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
JP2018519329A5 (cg-RX-API-DMAC7.html)
JP2017516860A5 (cg-RX-API-DMAC7.html)
JP2015519322A5 (cg-RX-API-DMAC7.html)
RU2013127655A (ru) Фармацевтическая комбинация паклитаксела и ингибитора cdk
RU2008107733A (ru) Ингибиторы gsk-3